IMV Inc. Stock Analysis IMVIF
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The company is headquartered in Dartmouth, Nova Scotia and currently employs 63 full-time employees. The company went IPO on 2018-06-01. The firm has sold all of its assets. The company is not engaged in any business operations.
Read More IMV Inc (IMVIF) Chart
Financial Metrics & Statements of IMV Inc (IMVIF)
FAQ's for IMV Inc (IMVIF)
- According to Musaffa’s Shariah screening methodology, IMV Inc (IMVIF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.